Granite Ridge Resources, Inc. Common Stock (GRNT)

Insiders are buying these stocks and show high conviction in their value, but there is a risk with a dividend cut with one of them.

GRNT stock results show that Granite Ridge Resources missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

By buying dividend stocks under $10, investors can rapidly maximize the value of their early investments in these industries.

GRNT stock results show that Granite Ridge Resources beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Discover seven promising stocks priced under $15, leading in sectors like financial services, biotechnology, and energy.

GRNT stock results show that Granite Ridge Resources met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

All of my research shows that when the market allows you to buy good companies at bargain valuations, patient-aggressive investors can earn outsized long-term returns. With that in mind, I can recommend Granite Ridge Resources.

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.

Oil prices have witnessed wild swings since the onset of the pandemic, reflecting that volatility is an integral part of the sector. Hence, creating a portfolio of low-beta energy stocks is paramount. Here are three such stocks to take a look at.

The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.

The shares sank to just over level of a secondary stock sale.

U.S. stock futures traded lower this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 1% on Monday. The Dow traded up 0.29% to 34,676.52 while the NASDAQ rose 1.16% to 13,920.60. The S&P 500, also rose, gaining, 0.66% to 4,486.98.

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 80 points on Monday. The Dow traded up 0.40% to 34,715.88 while the NASDAQ rose 0.58% to 13,841.50. The S&P 500, also rose, gaining, 0.52% to 4,480.87.

Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study in acromegaly.